310 likes | 470 Views
Goals of PEPFAR . During a 5-year period, the goals of PEPFAR areTo treat at least 2 million HIV-infected people with antiretroviral therapy (ART) To prevent 7 million new HIV infections, which is about 60% of the projected new infections in the 14 participating countries To care
E N D
1. PEPFAR Plansfor Initiating ART andProviding Laboratory Services Tedd V. Ellerbrock, MD, FACOGGlobal AIDS ProgramCenters for Disease Control and Prevention Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
2. Goals of PEPFAR During a 5-year period, the goals of PEPFAR are
To treat at least 2 million HIV-infected people with antiretroviral therapy (ART)
To prevent 7 million new HIV infections, which is about 60% of the projected new infections in the 14 participating countries
To care for 10 million HIV-affected individuals and AIDS orphans It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
3. Goals of PEPFAR During a 5-year period, the goals of PEPFAR are:
To treat at least 2 million HIV-infected people with antiretroviral therapy (ART)
To prevent 7 million new HIV infections, which is about 60% of the projected new infections in the 14 participating countries
To care for 10 million HIV-affected individuals and AIDS orphans It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
4. PEPFAR Plans for Initiating ARTand Providing Laboratory Services Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
5. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #1
What are the major factors that will determine how many HIV- infected persons will be treated through PEPFAR? The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
6. Major Factors that will Determine How Many HIV- infected Persons will be Treated through PEPFAR Goal of PEPFAR – treat at least 2 million with ART
Funding of PEPFAR – $10 billion over 5 years
Need – 20 million HIV-infected persons live in the 14 PEPFAR countries and at least 3 million (15%) of these qualify for ART
Feasibility – if we receive the funding, determining how many persons we can feasibly treat with ART will probably not be an option because those who are not treated are at risk of serious illness and death Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
7. Major Factors that will Determine How Many HIV- infected Persons will be Treated through PEPFAR Goal of PEPFAR – treat at least 2 million with ART
Funding of PEPFAR – $10 billion over 5 years
Need – 20 million HIV-infected persons live in the 14 PEPFAR countries and at least 3 million (15%) of these qualify for ART
Feasibility – if we receive the funding, determining how many persons we can feasibly treat with ART will probably not be an option because those who are not treated are at risk of serious illness and death Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
Thank you all for coming. I’m sorry we can’t see you, but it’s nice to talk with everyone.
We are proposing to initiate an antiretroviral treatment program.
This pilot initiative will be carried out by: The Kenya Ministry of Health, The St Mary’s Mission Hospital, Kibera Community Self Help Program, otherwise known as KICOSHEP, the Kenya medical Research Institute and CDC
8. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #1
What are the major factors that will determine how many HIV- infected persons will be treated through PEPFAR?
Response
The major factors that will determine how many persons will be treated through PEPFAR are probably the goals of PEPFAR, the funding for PEPFAR, and the need for ART; stating that a goal is not feasible may not be an option.
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
9. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #2
If we initiate ART for 2 million persons during the next 5 years, how many persons should we start on ART during the first year of PEPFAR? The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
10. Number of HIV-infected Persons Who Need to be Started on ART Annually during the Next 5 Years
11. Number of HIV-infected Persons Who Need to be Started on ART Annually during the Next 5 Years
200,000 – during the first year
300,000 – during the second year
400,000 – during the third year
500,000 – during the fourth year
600,000 – during the fifth year
2,000,000 – total during 5 years
It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
12. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #2
If we initiate ART for 2 million persons during the next 5 years, how many persons should we start on ART during the first year of PEPFAR?
Response
If we initiate ART for 2 million persons during the next 5 years, we estimate that about 200,000 will have to be started on ART during the first year of PEPFAR
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
13. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #3
How can we initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR?
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
14. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR Need to address issues related to:
Clinical care
Drugs and health commodities
Laboratory support
Training
Community mobilization
Monitoring and evaluation
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
15. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR
For laboratory support, we need to decide
which of the following services we can provide:
HIV diagnostics
Hematology
Chemistries
CD4+ counts
Viral loads
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
16. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR For each laboratory service, we need to need to address issues related to:
Training
Infrastructure
Equipment and supplies
Quality assurance
Information systems
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
17. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #3
How can we initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR?
Response
To initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR, we will probably have to provide only essential laboratory services in at least some settings
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
18. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #4
What laboratory services are essential for initiating ART for 200,000 persons during the first year of PEPFAR?
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
19. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR
Essential Laboratory Services
for the First Year of PEPFAR
(in order of priority)
HIV diagnostics
Diagnosis of TB
Diagnosis of malaria
CD4+ counts
Chemistries
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
20. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR
Essential Laboratory Services
for Large Urban Hospitals
during the First Year of PEPFAR
HIV diagnostics
Diagnosis of TB
Diagnosis of malaria
CD4+ counts
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
21. Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR
Essential Laboratory Services
for District Hospitals
during the First Year of PEPFAR
HIV diagnostics
Diagnosis of TB
Diagnosis of malaria
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
22. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #4
What laboratory services are essential for initiating ART for 200,000 persons during the first year of PEPFAR?
Response
In some settings, diagnostics for HIV, TB, and malaria may be the only laboratory services that we can provide during the first year of PEPFAR
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
23. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #5
How can we develop a strategic plan for laboratory services during the first year of PEPFAR? The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
24. Strategic Plan for Laboratory Services during the First Year of PEPFAR
For the services listed below, we could suggest objectives for each of 2 types of clinical settings (for example, for large urban and district hospitals) and make recommendations about how best to achieve these objectives:
HIV diagnostics
Hematology
Chemistries
CD4+ counts
Viral loads
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
25. Strategic Plan for Laboratory Services during the First Year of PEPFAR During this meeting, the work groups could develop first year objectives for 2-3 services for 2 types of clinical settings and make recommendations about how best to achieve these objectives
The objectives and recommendations could be reviewed and discussed during the work group presentations on the second day of the meeting
After the meeting, the objectives and recommendations could be compiled into a strategic plan for providing laboratory services during the first year of PEPFAR
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
26. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #5
How can we develop a strategic plan for laboratory services during the first year of PEPFAR?
Response
We can use the work groups during this meeting to develop a strategic plan for laboratory services during the first year of PEPFAR
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
27. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #6
How can we help to implement a strategic plan for laboratory services during the first year of PEPFAR? The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
28. Strategic Plan for Laboratory Services during the First Year of PEPFAR
By March 31, 2004, USG staff in each PEPFAR country has been asked to submit a country plan for the first year of PEPFAR
In consultation with in-country USG staff, we could organize a lab team to assist each PEPFAR country prepare the country plan for laboratory sevices for the first year of PEPFAR
The lab teams could use the strategic lab plan for the first year, developed initially at this meeting, as guidance when preparing the country plans
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
31. Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #6
How can we help to implement a strategic plan for laboratory services during the first year of PEPFAR?
Response
We can help implement a strategic plan for laboratory services during the first year of PEPFAR by using lab teams to help countries prepare their country plans for the first year during January – March 2004
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
The objectives of this pilot initiative are:
To develop and evaluate practical and locally appropriate ways of delivering ARVs
To enhance country capacity to provide ARVs in Kenya by developing training materials for health care personnel and community health workers, provide expertise and experience, and to demonstrate how to procure, store, and ensure uninterrupted supply of antiretroviral drugs.
And thirdly, to attract and absorb additional donor resources for AIDS treatment programs
32. Summary
To treat at least 2 million HIV-infected people with ART during 5 years, we will probably need to initiate ART for about 200,000 persons during the first year of PEPFAR
To initiate ART for 200,000 persons during the first year, we need to develop plans for providing laboratory services during the first year of PEPFAR
This meeting offers a unique opportunity to begin preparing a strategic laboratory plan that can be used to prepare country plans for the first year of PEPFAR It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.
It is a well-known fact that ARVs lead to reductions in mortality and morbidity arising from HIV infection.
In Kenya the HIV prevalence is estimated at 13% in adults aged 15- 49 years, with approximately 500 – 700 people dying daily of AIDS.
Despite this, ARVs are available to few people, mainly in the private sector due primarily to cost implications and complexity of ARV regimens.
As cost of AIDS treatment continues declining, there is potential for these therapies to become more accessible and it is therefore an important time to expand national capacity for safe and effective use of antiretroviral therapy in Kenya.